September 5, 2007Open Access

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

RCB determined from routine pathologic materials represented the distribution of RD, was a significant predictor of DRFS, and can be used to define categories of near-complete response and chemotherapy resistance.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Symmans et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d8e8a62c39562886ae3260 — DOI: https://doi.org/10.1200/jco.2007.10.6823

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome· 2007 · 306 citations
Resampling and cross-validation techniques: a tool to reduce bias caused by model building?· 1997 · 142 citations
Regression Modeling Strategies· 2001 · 9,255 citations
Assessing the Generalizability of Prognostic Information· 1999 · 1,191 citations

Authors

W. Fraser Symmans

Florentia Peintinger

Christos Hatzis

Journals

Journal of Clinical Oncology

Actions

Institutions

Nuvera Biosciences (United States)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion